GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $14.97 $17.43 Wednesday, 17th Apr 2024 CPRX stock ended at $16.00. This is 2.96% more than the trading day before Tuesday, 16th Apr 2024. During the day the stock fluctuated 2.82% from a day low at $15.62 to a day high of $16.06.
90 days $13.12 $17.50
52 weeks $11.09 $17.78

Historical Catalyst Pharmaceuticals prices

Date Open High Low Close Volume
2024-02-05 $13.45 $13.59 $13.32 $13.39 1 136 703
2024-02-02 $14.43 $14.43 $13.61 $13.62 1 283 482
2024-02-01 $14.51 $14.60 $14.34 $14.43 642 905
2024-01-31 $14.71 $14.84 $14.33 $14.40 1 315 275
2024-01-30 $14.41 $14.83 $14.33 $14.77 1 089 508
2024-01-29 $14.36 $14.54 $14.28 $14.45 1 285 994
2024-01-26 $14.50 $14.58 $14.25 $14.29 942 480
2024-01-25 $14.75 $14.81 $14.40 $14.53 949 451
2024-01-24 $15.06 $15.10 $14.60 $14.60 825 834
2024-01-23 $15.30 $15.35 $14.76 $14.93 890 792
2024-01-22 $14.63 $15.17 $14.48 $15.15 1 322 241
2024-01-19 $14.77 $14.77 $14.49 $14.56 747 356
2024-01-18 $14.65 $14.73 $14.21 $14.70 1 165 438
2024-01-17 $14.27 $14.70 $14.06 $14.58 1 146 249
2024-01-16 $14.50 $14.51 $14.11 $14.36 1 510 412
2024-01-12 $14.94 $14.94 $14.31 $14.49 1 346 507
2024-01-11 $15.00 $15.00 $14.60 $14.71 1 388 628
2024-01-10 $15.42 $15.50 $14.83 $15.09 1 860 070
2024-01-09 $15.04 $15.40 $14.79 $15.29 1 751 052
2024-01-08 $14.69 $15.11 $14.42 $15.11 5 241 395
2024-01-05 $14.58 $14.97 $14.44 $14.57 7 575 080
2024-01-04 $16.76 $17.19 $16.69 $17.11 700 730
2024-01-03 $16.99 $17.15 $16.59 $16.66 657 885
2024-01-02 $16.71 $17.19 $16.71 $17.11 708 818
2023-12-29 $17.20 $17.22 $16.74 $16.81 788 311
Click to get the best stock tips daily for free!

About Catalyst Pharmaceuticals

Catalyst Pharmaceuticals Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company also develop... CPRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT